Log in or create an account for full access to this data.
Create a free account or log in to use this tool.
Create a free account or log in to explore DrugBank data.
DB09129ApprovedSmall molecule
Chromic chloride is a supplement to intravenous solutions given for total parenteral nutrition (TPN). A nutrient used to provide nutrition to some patients in hospitals.
- Mechanism
- Curator reviewed
Metallic chromium has no biological activity. Chromium is referred as a glucose tolerance factor. This glucose tolerance factor is a complex of molecules. Glycine, cysteine, glutamic acid and nicotinic acid along with chromium form this complex.
- Primary indication
- For use as a supplement to intravenous solutions given for total parenteral nutrition (TPN).Curator reviewed · 1 structured indication
- Formula / weight
- Cl3Cr · 158.355 g/mol (avg)
- First approval
- Canada, 1996 · United States, 2016
- Also known as
- Chromium chloride · Chromium trichloride · chromium(3+) trichloride · Chromium(III) chloride · Puratronic chromium chloride
- Brand names
- Multitrace-4
- Multitrace-5
Resolves to
Clinical / RWD
Structure
InChIKey
QSWDMMVNRMROPK-UHFFFAOYSA-KSMILES[Cl-].[Cl-].[Cl-].[Cr+3]Targets
What you can answer from here — as of September 13, 2026
1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
Which drugs share a target with Chromic chloride, and which of those have an active Phase 3 trial?